SkySouth Expands Medical Transport in Southeast US

North Carolina-based SkySouth Aviation has announced an expansion of its private jet medical charter services, bolstering critical organ transport logistics across the Southeastern United States. The company, a charter operator and Fixed-Base Operator (FBO) at Burlington-Alamance Regional Airport (KBUY), recently surpassed 1,000 organ transport missions, underscoring its established role in the region's time-sensitive medical supply chain.

The expansion of SkySouth Aviation medical transport capabilities addresses a growing logistical challenge in healthcare: the increasing unreliability of commercial airlines for time-critical shipments. As hospital networks and organ procurement organizations face flight cancellations and restrictive cargo policies on commercial carriers, specialized operators operating under 14 CFR Part 135 regulations have become essential infrastructure. SkySouth's commitment provides a vital service to transplant centers and patients, where transport delays can directly impact the viability of an organ and the success of a surgery.

Operational Capabilities

SkySouth operates a fleet of Citation CJ1 (Cessna Model 525) and Citation CJ3 (Cessna Model 525B) light jets, available for dispatch 24/7. The Citation CJ3 organ transport capability is central to the service, offering a cruising speed of approximately 480 mph (416 knots) and a range of over 1,500 nautical miles. According to official specifications from manufacturer Textron Aviation, the CJ3 has a maximum range of 2,040 nautical miles, giving it the endurance to handle missions across the eastern half of the country without refueling.

This performance is critical for missions involving heart transplant teams, which frequently utilize the CJ3 for its speed and cabin space. The company recently refitted the aircraft's interior in January 2026 to better accommodate medical teams.

"When transplant surgeons and medical coordinators call us, minutes matter," said Kevin Mock, founder of SkySouth Aviation. "We have spent more than two decades building the systems, the team, and the reputation that hospitals trust when lives are on the line. This expansion reflects our commitment to being available whenever and wherever a medical network needs us across the Southeast."

Industry Context and Regulatory Framework

The move comes as the national transplant system, overseen by the United Network for Organ Sharing (UNOS) and the Organ Procurement and Transplantation Network (OPTN), evolves. Recent policy changes prioritize matching organs with the sickest patients, regardless of their geographic location. This has increased the average distance organs must travel, making the speed and range of private jets indispensable.

This trend is recognized at the federal level. The FAA Reauthorization Act of 2023 included provisions for a working group to establish best practices for transporting organs in aircraft cabins, a measure aimed at improving safety and chain of custody. SkySouth's operations align with this focus on specialized, reliable transport. The entire framework is governed by the FAA (Federal Aviation Administration), which ensures charter operators meet stringent safety and operational standards.

Technical Analysis

SkySouth's expansion is a microcosm of a broader shift in logistics where business aviation is filling critical service gaps left by commercial airlines. The decision to enhance its medical charter services is a direct response to two key industry drivers: the systemic unreliability of scheduled airline services for time-sensitive cargo and regulatory changes from the OPTN that necessitate longer-range, on-demand flights. This positions specialized Part 135 operators not as a luxury service, but as a crucial component of national healthcare infrastructure.

While private charters offer unparalleled speed, their higher operational costs present a challenge for the healthcare system. According to healthcare economists, this places financial strain on Organ Procurement Organizations. Furthermore, environmental groups note the higher per-flight carbon emissions, advocating for sustainable aviation solutions. However, for a transplant team with a viable organ and a waiting patient, the reliability and speed of a private jet currently offer the highest probability of a successful outcome, making it the preferred logistical tool despite the costs.

Aircraft Specifications

Cessna Citation CJ3 vs Embraer Phenom 300

Cessna Citation CJ3 vs Cessna Citation CJ1

What Comes Next

The broader field of organ transport logistics continues to evolve. Recommendations from the FAA and Department of Transportation working group on organ transport best practices are expected in late 2026. Concurrently, UNOS and NASA are proceeding with a confirmed partnership to test unmanned aerial vehicles (UAVs) for organ transport throughout 2026 and 2027, exploring how new technology can further reduce transit times and overcome logistical hurdles.

For SkySouth, the focus remains on leveraging its existing, proven fleet to meet the immediate needs of the medical community in the Southeast. The expansion solidifies its position as a key partner for hospitals in North Carolina and surrounding states.

Why This Matters

This expansion is more than a regional business development; it represents a strengthening of critical medical infrastructure. By providing reliable, on-demand air transport, SkySouth Aviation directly helps reduce organ cold ischemia time, a key factor in transplant success. The move highlights the growing and essential role that specialized private aviation plays in supporting public health logistics, ensuring that life-saving organs reach their destinations safely and swiftly.